MEDIPURE SCANDINAVIA A/S: Financial statements 2019
CVR: 13275149
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
MEDIPURE SCANDINAVIA A/S (CVR 13275149) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 108,810 and a net result of DKK 79,907 compared with DKK -112,495 the year before. Equity in the 2019 report amounted to DKK 1,421,399. The solvency ratio was 98.5%.
- Gross Profit
- DKK 108,810
- Profit/Loss
- DKK 79,907
- Equity
- DKK 1,421,399
- Total Assets
- DKK 1,443,051
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 109K | 80K | 1.4M | - |
| 2018 | - | -66K | -112K | 1.6M | - |
| 2017 | - | 269K | 158K | 1.8M | - |
| 2016 | - | 89K | 90K | 1.6M | - |
| 2015 | - | 95K | 170K | 1.5M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout MEDIPURE SCANDINAVIA A/S
MEDIPURE SCANDINAVIA A/S was a Danish company of the type Aktieselskab based in Risskov, founded in 1989. The company has been dissolved on 12 November 2025. The company was registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BAXA INTERNATIONAL ApS and ASX 14709 ApS. The company has 1 employee (2009). In 2024, the company reported a gross profit of DKK -24,760 and a net result of DKK -4,255 compared with DKK -5,675 the year before. Equity in the 2024 report amounted to DKK 789,098.
